You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idarubicin

Showing 1 - 25 of 319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Hepatocellular Carcinoma Trial in Nanjing (Idarubicin Hydrochloride for Injection)

Recruiting
  • Hepatocellular Carcinoma
  • Idarubicin Hydrochloride for Injection
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Dec 28, 2022

Hepatocellular Carcinoma Trial in Nanjing (cTACE(conventional transarterial chemoembolization))

Recruiting
  • Hepatocellular Carcinoma
  • cTACE(conventional transarterial chemoembolization)
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Dec 28, 2022

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

Recruiting
  • Leukemia, Myeloid, Acute
  • Idarubicin
  • Seoul, Korea, Republic of
    Division of Hematology-Oncology, Konkuk University Medical Cente
Apr 8, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Idarubicin Hydrochloride for Injection, Epirubicin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Carcinoma, Hepatocellular Trial in France (Idarubicin and Lipiodol)

Recruiting
  • Carcinoma, Hepatocellular
  • Idarubicin and Lipiodol
  • Angers, France
  • +3 more
Dec 24, 2021

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
Aug 1, 2021

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)

Recruiting
  • Acute Myeloid Leukemia
  • Calaspargase pegol-mknl
  • Baltimore, Maryland
    Greenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Acute Myeloid Leukemia Trial in Beijing (Idarubicin and cytarabine induction)

Recruiting
  • Acute Myeloid Leukemia
  • Idarubicin and cytarabine induction
  • Beijing, Beijing, China
    Xinxin Cao
Jun 7, 2021

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022